Wednesday, November 13, 2024

August 1, 2024 5:26 PM

Lilly says weight loss drug cut heart failure risk by 38% in trial

Trial results show Eli Lilly's weight loss drug Zepbound reduces the risk of hospitalization, death and other outcomes for obese adults with a common type of heart failure, the company said on Thursday as it continues to build a case for the medicati...

Copyright © 2024 DD India. All rights reserved

Visitors: 2600843

Last updated on: 12th November 2024